Gene therapy for diabetic ischemic disease

Details Gene therapy for diabetic ischemic disease Gene therapy for diabetic ischemic disease

A - Human Necessities

61

K

A61K 48/00 (2006.01) A61K 9/127 (2006.01) A61K 38/18 (2006.01) A61K 38/22 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) C07K 14/475 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2356701

It is possible to stimulate the angiogenesis of an ischemic site declined by diabetes and to recuperate ischemic disease by administering HGF (hepatocyte growth factor) gene to the diabetic ischemic site.

L'administration d'un gène HGF (facteur de croissance hépatocyte) à un site ischémique diabétique à pour effet de favoriser l'angiogenèse du site ischémique avec la dépression provoquée par le diabète, permettant ainsi de guérir d'une maladie ischémique.

Affiliated with

Also associated with

Rating

Gene therapy for diabetic ischemic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene therapy for diabetic ischemic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy for diabetic ischemic disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1929785